Welspun Enterprises Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 10, 2025, 10:51 pm

Competitors of Welspun Enterprises Ltd

All Competitor Stocks of Welspun Enterprises Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:10 am

Below is a detailed analysis of the quarterly data for Welspun Enterprises Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 845.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,054.00 Cr. (Mar 2025) to 845.00 Cr., marking a decrease of 209.00 Cr..
• For Expenses, as of Jun 2025, the value is 664.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 871.00 Cr. (Mar 2025) to 664.00 Cr., marking a decrease of 207.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 181.00 Cr.. The value appears to be declining and may need further review. It has decreased from 183.00 Cr. (Mar 2025) to 181.00 Cr., marking a decrease of 2.00 Cr..
• For OPM %, as of Jun 2025, the value is 21.00%. The value appears strong and on an upward trend. It has increased from 17.00% (Mar 2025) to 21.00%, marking an increase of 4.00%.
• For Other Income, as of Jun 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 17.00 Cr. (Mar 2025) to 13.00 Cr., marking a decrease of 4.00 Cr..
• For Interest, as of Jun 2025, the value is 42.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 44.00 Cr. (Mar 2025) to 42.00 Cr., marking a decrease of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 11.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 15.00 Cr. (Mar 2025) to 11.00 Cr., marking a decrease of 4.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 141.00 Cr.. The value appears to be declining and may need further review. It has decreased from 142.00 Cr. (Mar 2025) to 141.00 Cr., marking a decrease of 1.00 Cr..
• For Tax %, as of Jun 2025, the value is 28.00%. The value appears to be increasing, which may not be favorable. It has increased from 26.00% (Mar 2025) to 28.00%, marking an increase of 2.00%.
• For Net Profit, as of Jun 2025, the value is 101.00 Cr.. The value appears to be declining and may need further review. It has decreased from 105.00 Cr. (Mar 2025) to 101.00 Cr., marking a decrease of 4.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 6.56. The value appears to be declining and may need further review. It has decreased from 6.83 (Mar 2025) to 6.56, marking a decrease of 0.27.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:08 am

Growth

Last Updated: September 5, 2025, 1:56 pm

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Welspun Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 23.61. This value is within the healthy range. It has increased from 21.51 (Mar 24) to 23.61, marking an increase of 2.10.
• For Diluted EPS (Rs.), as of Mar 25, the value is 23.30. This value is within the healthy range. It has increased from 21.25 (Mar 24) to 23.30, marking an increase of 2.05.
• For Cash EPS (Rs.), as of Mar 25, the value is 29.76. This value is within the healthy range. It has increased from 25.46 (Mar 24) to 29.76, marking an increase of 4.30.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 185.81. It has increased from 182.42 (Mar 24) to 185.81, marking an increase of 3.39.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 185.81. It has increased from 182.42 (Mar 24) to 185.81, marking an increase of 3.39.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 262.17. It has increased from 210.41 (Mar 24) to 262.17, marking an increase of 51.76.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 53.41. This value is within the healthy range. It has increased from 45.16 (Mar 24) to 53.41, marking an increase of 8.25.
• For PBIT / Share (Rs.), as of Mar 25, the value is 49.69. This value is within the healthy range. It has increased from 43.14 (Mar 24) to 49.69, marking an increase of 6.55.
• For PBT / Share (Rs.), as of Mar 25, the value is 38.19. This value is within the healthy range. It has increased from 35.10 (Mar 24) to 38.19, marking an increase of 3.09.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 26.04. This value is within the healthy range. It has increased from 23.44 (Mar 24) to 26.04, marking an increase of 2.60.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 23.59. This value is within the healthy range. It has increased from 21.62 (Mar 24) to 23.59, marking an increase of 1.97.
• For PBDIT Margin (%), as of Mar 25, the value is 20.37. This value is within the healthy range. It has decreased from 21.46 (Mar 24) to 20.37, marking a decrease of 1.09.
• For PBIT Margin (%), as of Mar 25, the value is 18.95. This value is within the healthy range. It has decreased from 20.50 (Mar 24) to 18.95, marking a decrease of 1.55.
• For PBT Margin (%), as of Mar 25, the value is 14.56. This value is within the healthy range. It has decreased from 16.68 (Mar 24) to 14.56, marking a decrease of 2.12.
• For Net Profit Margin (%), as of Mar 25, the value is 9.93. This value is within the healthy range. It has decreased from 11.14 (Mar 24) to 9.93, marking a decrease of 1.21.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.99. This value is within the healthy range. It has decreased from 10.27 (Mar 24) to 8.99, marking a decrease of 1.28.
• For Return on Networth / Equity (%), as of Mar 25, the value is 12.69. This value is below the healthy minimum of 15. It has decreased from 12.70 (Mar 24) to 12.69, marking a decrease of 0.01.
• For Return on Capital Employeed (%), as of Mar 25, the value is 16.55. This value is within the healthy range. It has decreased from 17.50 (Mar 24) to 16.55, marking a decrease of 0.95.
• For Return On Assets (%), as of Mar 25, the value is 5.32. This value is within the healthy range. It has decreased from 5.96 (Mar 24) to 5.32, marking a decrease of 0.64.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.49. This value is within the healthy range. It has increased from 0.24 (Mar 24) to 0.49, marking an increase of 0.25.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.58. This value is within the healthy range. It has increased from 0.32 (Mar 24) to 0.58, marking an increase of 0.26.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.65. It has increased from 0.57 (Mar 24) to 0.65, marking an increase of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 1.86. This value is within the healthy range. It has decreased from 2.03 (Mar 24) to 1.86, marking a decrease of 0.17.
• For Quick Ratio (X), as of Mar 25, the value is 1.78. This value is within the healthy range. It has decreased from 1.93 (Mar 24) to 1.78, marking a decrease of 0.15.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 22.45. This value exceeds the healthy maximum of 8. It has increased from 3.87 (Mar 24) to 22.45, marking an increase of 18.58.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 12.69. This value is below the healthy minimum of 20. It has increased from 4.62 (Mar 24) to 12.69, marking an increase of 8.07.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 10.96. This value is below the healthy minimum of 20. It has increased from 4.22 (Mar 24) to 10.96, marking an increase of 6.74.
• For Earning Retention Ratio (%), as of Mar 25, the value is 87.31. This value exceeds the healthy maximum of 70. It has decreased from 95.38 (Mar 24) to 87.31, marking a decrease of 8.07.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 89.04. This value exceeds the healthy maximum of 70. It has decreased from 95.78 (Mar 24) to 89.04, marking a decrease of 6.74.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.62. This value is within the healthy range. It has decreased from 5.61 (Mar 24) to 4.62, marking a decrease of 0.99.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.44. This value is within the healthy range. It has decreased from 4.18 (Mar 24) to 3.44, marking a decrease of 0.74.
• For Enterprise Value (Cr.), as of Mar 25, the value is 7,626.70. It has increased from 4,598.04 (Mar 24) to 7,626.70, marking an increase of 3,028.66.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.13. This value is within the healthy range. It has increased from 1.60 (Mar 24) to 2.13, marking an increase of 0.53.
• For EV / EBITDA (X), as of Mar 25, the value is 10.44. This value is within the healthy range. It has increased from 7.46 (Mar 24) to 10.44, marking an increase of 2.98.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.84. This value is within the healthy range. It has increased from 1.45 (Mar 24) to 1.84, marking an increase of 0.39.
• For Retention Ratios (%), as of Mar 25, the value is 87.30. This value exceeds the healthy maximum of 70. It has decreased from 95.37 (Mar 24) to 87.30, marking a decrease of 8.07.
• For Price / BV (X), as of Mar 25, the value is 2.60. This value is within the healthy range. It has increased from 1.79 (Mar 24) to 2.60, marking an increase of 0.81.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.84. This value is within the healthy range. It has increased from 1.45 (Mar 24) to 1.84, marking an increase of 0.39.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.07 (Mar 24) to 0.04, marking a decrease of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness